首页> 外文OA文献 >Estimating The Economic Benefit Of Treatment With Alpha-Blocker Plus Antimuscarinic As A Fixed-Dose Combination (FDC) Tablet Versus Concomitant Combination Therapy (CCT) In Men With Lower Urinary Tract Symptoms (Luts) Associated With Benign Prostatic Hyperplasia (BPH)

【2h】

Estimating The Economic Benefit Of Treatment With Alpha-Blocker Plus Antimuscarinic As A Fixed-Dose Combination (FDC) Tablet Versus Concomitant Combination Therapy (CCT) In Men With Lower Urinary Tract Symptoms (Luts) Associated With Benign Prostatic Hyperplasia (BPH)

机译：估计α-嵌体加抗血清胰岛素作为固定剂量组合（FDC）片剂的经济效益，与患有良性前列腺增生（BPH）相关的男性的伴随组合治疗（CCT），伴随着尿路症状（LUT）

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
S Bowditch; C McCrea; E Arbe; J Nazir;
展开▼
作者单位

展开▼
年度 2017
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
专利

1. Evaluation of the impact of dutasteride/tamsulosin combination therapy on libido in sexually active men with lower urinary tract symptoms ( LUTS LUTS ) secondary to benign prostatic hyperplasia ( BPH BPH ): A post hoc analysis of a prospective randomised placebo‐controlled study [J] . Rosen Raymond C., Roehrborn Claus G., Manyak Michael J., International journal of clinical practice . 2019,第9期

机译：评价荷兰特德/汀类药物组合治疗对性活性男性的性活性男性的影响（LUTS LUTS）继发于良性前列腺增生（BPH BPH）的影响：对预期随机安慰剂对照研究的后HOC分析
2. A prospective randomised placebo‐controlled study of the impact of dutasteride/tamsulosin combination therapy on sexual function domains in sexually active men with lower urinary tract symptoms ( LUTS LUTS ) secondary to benign prostatic hyperplasia ( BPH BPH ) [J] . Roehrborn Claus G., Manyak Michael J., Palacios‐Moreno Juan Manuel, BJU international . 2018,第4期

机译：一项预期随机安慰剂对照研究荷兰芹酰胺/茶香素组合治疗对性活性男性的性函数域的影响，患有低尿路症状（LUTS LUTS）继发于良性前列腺增生（BPH BPH）
3. Combination therapy with omega-3 fatty acids plus tamsulocin and finasteride in the treatment of men with lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH) [J] . Ghadian Alireza, Rezaei Mehran Inflammopharmacology . 2017,第4期

机译：ω-3脂肪酸的组合治疗加上杜鹃花和多赛斯蒂德治疗尿路症状（LUT）和良性前列腺增生（BPH）的男性
4. Patient’s adherence on pharmacological therapy for benign prostatic hyperplasia (BPH)-associated lower urinary tract symptoms (LUTS) is different: is combination therapy better than monotherapy? [O] . Luca Cindolo, Luisella Pirozzi, Petros Sountoulides, 2015

机译：患者对良性前列腺增生（BPH）相关的下尿路症状（LUTS）的药物治疗依从性不同：联合治疗优于单一治疗吗？
5. PUK9 COST-EFFECTIVENESS ANALYSIS OF ALPHA-BLOCKER AND ANTIMUSCARINIC COMBINATION TREATMENT IN MEN WITH LOWER URINARY TRACT SYMPTOMS RELATED TO BENIGN PROSTATIC HYPERPLASIA AND OVERACTIVE BLADDER: APPLICATION TO THE UNITED KINGDOM [O] . Verheggen BG, Lee R, Treur MJ, 2009

机译：与前列腺肥大和膀胱过度活动症相关的下尿路症状较低的男性中α-受体阻滞剂和抗绝症联合疗法的PUK9成本效益分析：在英国的应用

Estimating The Economic Benefit Of Treatment With Alpha-Blocker Plus Antimuscarinic As A Fixed-Dose Combination (FDC) Tablet Versus Concomitant Combination Therapy (CCT) In Men With Lower Urinary Tract Symptoms (Luts) Associated With Benign Prostatic Hyperplasia (BPH)

著录项

引文网络

相似文献

相关主题

期刊订阅